Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice

Acta Pharmacologica Sinica

Volumn 25, Issue 7, 2004, Pages 966-972

  Wu, Zheng Hong ^a   Ping, Qi Neng ^a   Wei, Yi ^a   Lai, Jia Ming ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Blood glucose; Chitin; Chitosan; Insulin; Liposomes; Oral administration

Indexed keywords

CHITOSAN; GLUCOSE OXIDASE; INSULIN; INSULIN LIPOSOME; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COATING; DRUG EFFICACY; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CHITIN; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYPOGLYCEMIC AGENTS; INSULIN; LIPOSOMES; MALE; MICE; PARTICLE SIZE; TECHNOLOGY, PHARMACEUTICAL;

EID: 3142657233     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kisel MA, Kulik L, Tsybovsky IS, Vlasov AP, Vorob'Yov MS, Kholodova EA, et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int J Pharm 2001; 216: 105-14.
2. Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res 1996; 13: 896-901.
3. Kas HS. Chitosan: properties, preparations and application to microparticulate systems. J Microencapsul 1997; 14: 689-711.
4. Henriksen I, Vagen SR, Sande SA, Smistad G, Karlsen J. Interaction between liposomes and chitosan II: effect of selected parameters on aggregation and leakage. Int J Pharm 1997; 146: 193-204.
5. Lehr C, Bouwstra JA, Schacht EH, Junginer HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 1992; 76: 43-9.
6. He P, Davis SS, Illum L. In vitro evaluation of mucoadhesive properties of chitosan micro spheres. Int J Pharm 1998; 166: 75-88.
7. Schipper NGM, Olsson S, Hoogstraate JA, deBeor AG, Varum KM, Artursson P. Chitosans as absorption enhancers for poorly absorbable drug 2: Mechanism of absorption enhancement. Pharm Res 1997; 14: 923-9.
8. Henriksen I, Smistad G, Karlsen J. Interaction between liposomes and chitosan. Int J Pharm 1994; 101: 227-36.
9. Aspeden TJ, Mason JDT, Jones NS, Lowe J, Skaugrud F, Illum L. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci 1997; 86: 509-13
10. Kotze AF, Lueben HL, Leeuw BJ, deBeor AG, Verhoef JC, Junginer HE. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Rel 1998; 51: 35-46.
11. Dung PL, Milas M, Rinaudo M, Desbrieres J. Water soluble derivatives obtained by controlled chemical modifications of chitosan. Carbohydrate Polymers 1994; 24: 209-14.
12. Filipovic-Grcic J, Skalko-Basnet N, Jalsenjal I. Mucoadhesive chitosan-coated liposomes: characteristics and stability. J Microencapsul 2001; 18: 3-12.
13. Banakar UV. Advances and opportunities on delivery of therapeutic proteins and peptides. J Biomater Appl 1997; 11: 377-429.
14. Artursson P, Lindmark T, Davis SS, Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 1994; 11: 1358-61.
15. Polk A, Amsden B, Yao KD, Peng T, Goosen MFA. Controlled release of albumin from chitosan-alginate microcapsules. J Pharm Sci 1994; 83: 178-85.